Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors

Clinical trial NCT07100054 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07100054
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

CDK4/6 Inhibitor Breast Cancer CYP3A4 Protein, Human Drug Interaction Pharmacogenetic Testing

Start date: 2025-10-10
Primary completion: 2028-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.